Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15058 | 29115682 | Aliment Pharmacol Ther | Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. | 2017 | Details |
| A15059 | 29114377 | Int J Prev Med | Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome. | 2017 | Details |
| A15060 | 29114108 | Acta Inform Med | Therapeutic Effects of Curcumin on Ultrasonic Morphological Characteristics of Liver in Patients with Metabolic Syndrome. | 2017 | Details |
| A15061 | 29113910 | J Hepatol | The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. | 2017 | Details |
| A15062 | 29113741 | Cytokine | Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2017 | Details |
| A15063 | 29113510 | Diab Vasc Dis Res | Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. | 2017 | Details |
| A15064 | 29113135 | Nutrients | Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15065 | 29113028 | Hepatology | Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. | 2018 | Details |
| A15066 | 29112771 | Clin Exp Pharmacol Physiol | Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease. | 2017 | Details |
| A15067 | 29111276 | Diabetes Res Clin Pract | The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study. | 2017 | Details |
| A15068 | 29111158 | Cell Immunol | Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool. | 2017 | Details |
| A15069 | 29109528 | Sci Rep | Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study. | 2017 | Details |
| A15070 | 29109457 | Sci Rep | Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients. | 2017 | Details |
| A15071 | 29109303 | Clin Sci (Lond) | Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? | 2017 | Details |
| A15072 | 29108214 | Zhonghua Gan Zang Bing Za Zhi | [Association between intestinal flora imbalance and nonalcoholic fatty liver disease]. | 2017 | Details |
| A15073 | 29108205 | Zhonghua Gan Zang Bing Za Zhi | [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China]. | 2017 | Details |
| A15074 | 29108191 | Zhonghua Gan Zang Bing Za Zhi | [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017]. | 2017 | Details |
| A15075 | 29108123 | Hepatology | Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. | 2018 | Details |
| A15076 | 29107687 | Biochem Biophys Res Commun | MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator. | 2017 | Details |
| A15077 | 29107287 | Mol Metab | Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury. | 2017 | Details |
| A15078 | 29107284 | Mol Metab | Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice. | 2017 | Details |
| A15079 | 29106945 | Metabolism | Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. | 2017 | Details |
| A15080 | 29106426 | Food Funct | Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats. | 2017 | Details |
| A15081 | 29106384 | J Clin Invest | Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. | 2017 | Details |
| A15082 | 29106066 | J Dig Dis | Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. | 2017 | Details |
| A15083 | 29104811 | Liver Res | Bile acid metabolism and signaling in liver disease and therapy. | 2017 | Details |
| A15084 | 29104641 | Exp Ther Med | Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol. | 2017 | Details |
| A15085 | 29104232 | Antioxidants (Basel) | Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. | 2017 | Details |
| A15086 | 29104128 | Clin Gastroenterol Hepatol | Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease. | 2018 | Details |
| A15087 | 29104004 | Surg Obes Relat Dis | Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. | 2017 | Details |
| A15090 | 29101772 | Rom J Intern Med | Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth. | 2018 | Details |
| A15091 | 29101357 | Sci Rep | MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1. | 2017 | Details |
| A15092 | 29100781 | Steroids | Estrogens and female liver health. | 2017 | Details |
| A15093 | 29099543 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2017 | Details |
| A15094 | 29099463 | J Clin Gastroenterol | Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth). | 2019 | Details |
| A15095 | 29098545 | Obes Surg | Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. | 2018 | Details |
| A15096 | 29098121 | Curr Pathobiol Rep | Using zebrafish to model liver diseases-Where do we stand? | 2017 | Details |
| A15097 | 29098111 | Liver Res | Bile acid receptors link nutrient sensing to metabolic regulation. | 2017 | Details |
| A15098 | 29097288 | Diabetes Res Clin Pract | Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. | 2017 | Details |
| A15099 | 29097281 | Biochimie | Steatosis and NASH in type 2 diabetes. | 2017 | Details |
| A15100 | 29096730 | Gene Expr | Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights. | 2017 | Details |
| A15101 | 29095942 | PLoS One | Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease. | 2017 | Details |
| A15102 | 29094442 | Diabet Med | Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital. | 2018 | Details |
| A15103 | 29093267 | JCI Insight | Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. | 2017 | Details |
| A15104 | 29092796 | Mol Metab | AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice. | 2017 | Details |
| A15106 | 29091299 | Hepatology | Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. | 2018 | Details |
| A15107 | 29090980 | J Med Food | Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat Diets. | 2017 | Details |
| A15108 | 29090700 | Food Funct | Averrhoa carambola free phenolic extract ameliorates nonalcoholic hepatic steatosis by modulating mircoRNA-34a, mircoRNA-33 and AMPK pathways in leptin receptor-deficient db/db mice. | 2017 | Details |
| A15109 | 29090431 | J Endocrinol Invest | Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. | 2017 | Details |
| A15110 | 29089934 | Front Microbiol | Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver. | 2017 | Details |
| A15111 | 29089822 | Korean J Radiol | Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study. | 2017 | Details |
| A15112 | 29089335 | Am J Physiol Endocrinol Metab | Effects of periconceptional maternal alcohol intake and a postnatal high-fat diet on obesity and liver disease in male and female rat offspring. | 2017 | Details |
| A15113 | 29088835 | Oncotarget | Impact of non-alcoholic fatty liver disease and smoking on colorectal polyps. | 2017 | Details |
| A15114 | 29088779 | Oncotarget | The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism. | 2017 | Details |
| A15115 | 29087391 | Am J Gastroenterol | Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. | 2017 | Details |
| A15116 | 29086488 | J Diabetes Investig | Molecular mechanism of obesity-induced 'metabolic' tissue remodeling. | 2017 | Details |
| A15117 | 29086016 | J Gastroenterol | Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma. | 2017 | Details |
| A15118 | 29085919 | Hepatol Commun | MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A15119 | 29085877 | Data Brief | Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats. | 2017 | Details |
| A15120 | 29085788 | J Transl Int Med | Effect of Pentoxifylline on Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A One Year Randomized Control Trial. | 2017 | Details |
| A15121 | 29085434 | Evid Based Complement Alternat Med | Effect of Seyoeum on Obesity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease of High-Fat Diet-Fed C57BL/6 Mice. | 2017 | Details |
| A15122 | 29085222 | World J Gastroenterol | Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. | 2017 | Details |
| A15123 | 29085206 | World J Gastroenterol | Nonalcoholic fatty liver disease: Evolving paradigms. | 2017 | Details |
| A15124 | 29085205 | World J Gastroenterol | Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. | 2017 | Details |
| A15125 | 29084519 | BMC Public Health | Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. | 2017 | Details |
| A15126 | 31196637 | Ann Hepatol | Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances. | 2017 | Details |
| A15128 | 29083323 | J Clin Invest | Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. | 2017 | Details |
| A15129 | 29083080 | Intern Med J | Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. | 2018 | Details |
| A15130 | 29083037 | Aliment Pharmacol Ther | Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. | 2017 | Details |
| A15131 | 29083036 | Aliment Pharmacol Ther | Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15132 | 29082798 | Expert Rev Gastroenterol Hepatol | The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives. | 2017 | Details |
| A15133 | 29081885 | Oxid Med Cell Longev | Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice. | 2017 | Details |
| A15134 | 29080393 | Rom J Intern Med | Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study. | 2018 | Details |
| A15135 | 29080343 | Ann Hepatol | Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances. | 2017 | Details |
| A15136 | 29080046 | Curr Gastroenterol Rep | The Microbiome That Shapes Us: Can It Cause Obesity? | 2017 | Details |
| A15137 | 29079763 | Sci Rep | Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. | 2017 | Details |
| A15138 | 29077769 | PLoS One | The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter. | 2017 | Details |
| A15139 | 29077714 | PLoS One | Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study. | 2017 | Details |
| A15140 | 29077272 | J Cell Mol Med | Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease. | 2017 | Details |
| A15141 | 29077210 | Hepatology | Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. | 2018 | Details |
| A15142 | 29076670 | J Ayub Med Coll Abbottabad | Effects of nigella sativa on various parameters in Patients of non-alcoholic fatty liver disease. | 2019 | Details |
| A15143 | 29076589 | APMIS | Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study. | 2017 | Details |
| A15144 | 29075899 | J Gastroenterol | Immunoglobulin A and liver diseases. | 2017 | Details |
| A15145 | 29074727 | Gut | Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. | 2017 | Details |
| A15146 | 29074725 | Gut | Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. | 2017 | Details |
| A15147 | 29074597 | Diabetes | S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy. | 2017 | Details |
| A15148 | 29073252 | PLoS One | Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study. | 2017 | Details |
| A15149 | 29073197 | PLoS One | Etiology and mode of presentation of chronic liver diseases in India: A multi centric study. | 2017 | Details |
| A15150 | 29073130 | PLoS One | Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study. | 2017 | Details |
| A15151 | 29073114 | Proc Natl Acad Sci U S A | Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms. | 2017 | Details |
| A15153 | 29072704 | Cell Death Dis | Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice. | 2017 | Details |
| A15154 | 29072011 | Zhen Ci Yan Jiu | [Effect of Electroacupunctrue Stimulation at "Fenglong"(ST 40) on Expression of SREBP-1 c in Non-alcoholic Fatty Liver Disease Rats]. | 2017 | Details |
| A15155 | 29071867 | Zhongguo Zhong Yao Za Zhi | [Effects of three Wenyang Jianpi Tang on cell proliferation and apoptosis of nonalcoholic fatty liver cells]. | 2017 | Details |
| A15156 | 29070903 | Sci Rep | Increasing Dietary Medium-Chain Fatty Acid Ratio Mitigates High-fat Diet-Induced Non-Alcoholic Steatohepatitis by Regulating Autophagy. | 2017 | Details |
| A15157 | 29069580 | Eur J Pharmacol | Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG ratios and reducing oxidative and inflammatory stress. | 2017 | Details |
| A15158 | 29067443 | Mol Med Rep | Role of ADAMTS13 in diet-induced liver steatosis. | 2017 | Details |
| A15159 | 29067150 | Frontline Gastroenterol | Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey. | 2017 | Details |
| A15160 | 29067086 | Pak J Med Sci | The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs. | 2020 | Details |
| A15161 | 29067068 | Pak J Med Sci | Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients. | 2020 | Details |
| A15162 | 29066788 | Sci Rep | Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. | 2017 | Details |